Need Help?
Click here and start chatting with us!
Global AI-enabled medical device market revenue is projected to grow steeply from $3,200 Million in 2021, attaining $11,450 Million by 2025 and crossing $47,800 Million by 2035. The compound annual growth rate (CAGR) is bolstered by rapid AI advancements, increasing adoption by healthcare systems, and favorable regulatory support. Major leaps in market size are attributed to the proliferation of cloud-enabled, interoperable devices and the incorporation of AI in diagnostics and therapy. The upward trajectory is poised to persist as AI becomes integral to healthcare delivery and management.
Read More - https://bussinessinsights.com/research-report/global-ai-enabled-medical-devices-market
Radiology remains the most significant application area for AI-enabled medical devices, holding a 34% market share in 2025 due to increasing AI adoption in imaging diagnostics. Cardiology follows at 20% as AI-driven predictive analytics gain traction for heart disease management. Neurology (16%), Oncology (13%), Orthopedics (10%), and Others (7%) also contribute, reflecting AI’s expanding influence across multiple specialties. This segmentation underscores the market's focus on leveraging AI for early disease detection, patient stratification, and tailored treatment planning.
Request Free Sample- https://bussinessinsights.com/request/healthcare/global-ai-enabled-medical-devices-market
Who are the key players in Global AI-Enabled Medical Devices Market industry?
The top five players in the global AI-enabled medical devices market include Medtronic, Siemens Healthineers, GE Healthcare, Philips Healthcare, and IBM Watson Health. These companies provide innovative AI infrastructure, advanced imaging technologies, and data analytics platforms, driving digital transformation within healthcare and enhancing clinical decision-making capabilities.
What is the Global AI-Enabled Medical Devices Market growth?
The Global AI-Enabled Medical Devices Market has experienced robust growth in recent years, with a CAGR exceeding 25% from 2020 to 2023. In 2023, Medtronic reported a surge in demand for AI-powered diagnostic and monitoring devices, reflecting the market's expansion and rising adoption in clinical settings.
Which segment accounted for the largest Global AI-Enabled Medical Devices Market share?
The diagnostic imaging segment accounts for the largest share in the Global AI-Enabled Medical Devices Market. AI-powered imaging solutions, especially those provided by Siemens Healthineers and GE Healthcare, are critical for early disease detection, accurate diagnostics, and workflow automation, leading adoption by hospitals and diagnostic centers worldwide.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com